Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 2
2000 2
2003 2
2004 2
2005 5
2006 1
2007 3
2008 4
2009 4
2010 4
2011 3
2012 2
2013 5
2014 8
2015 5
2016 5
2017 1
2018 6
2019 4
2020 3
2021 2
2022 5
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

69 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma.
Domblides C, Leroy K, Monnet I, Mazières J, Barlesi F, Gounant V, Baldacci S, Mennecier B, Toffart AC, Audigier-Valette C, Doucet L, Giroux-Leprieur E, Guisier F, Ricordel C, Molinier O, Perol M, Pichon E, Robinet G, Templement-Grangerat D, Ruppert AM, Rabbe N, Antoine M, Wislez M. Domblides C, et al. Among authors: mennecier b. J Thorac Oncol. 2020 May;15(5):860-866. doi: 10.1016/j.jtho.2020.01.014. Epub 2020 Jan 25. J Thorac Oncol. 2020. PMID: 31991225 Free article.
Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial.
Moro-Sibilot D, Cozic N, Pérol M, Mazières J, Otto J, Souquet PJ, Bahleda R, Wislez M, Zalcman G, Guibert SD, Barlési F, Mennecier B, Monnet I, Sabatier R, Bota S, Dubos C, Verriele V, Haddad V, Ferretti G, Cortot A, De Fraipont F, Jimenez M, Hoog-Labouret N, Vassal G. Moro-Sibilot D, et al. Among authors: mennecier b. Ann Oncol. 2019 Dec 1;30(12):1985-1991. doi: 10.1093/annonc/mdz407. Ann Oncol. 2019. PMID: 31584608 Free article. Clinical Trial.
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial.
Rizvi NA, Mazières J, Planchard D, Stinchcombe TE, Dy GK, Antonia SJ, Horn L, Lena H, Minenza E, Mennecier B, Otterson GA, Campos LT, Gandara DR, Levy BP, Nair SG, Zalcman G, Wolf J, Souquet PJ, Baldini E, Cappuzzo F, Chouaid C, Dowlati A, Sanborn R, Lopez-Chavez A, Grohe C, Huber RM, Harbison CT, Baudelet C, Lestini BJ, Ramalingam SS. Rizvi NA, et al. Among authors: mennecier b. Lancet Oncol. 2015 Mar;16(3):257-65. doi: 10.1016/S1470-2045(15)70054-9. Epub 2015 Feb 20. Lancet Oncol. 2015. PMID: 25704439 Free PMC article. Clinical Trial.
[Afatinib (BIBW 2992)].
Prim N, Fore M, Mennecier B. Prim N, et al. Among authors: mennecier b. Rev Pneumol Clin. 2014 Oct;70(5):279-85. doi: 10.1016/j.pneumo.2014.03.002. Epub 2014 May 27. Rev Pneumol Clin. 2014. PMID: 24878189 Review. French.
[Lung cancer and pollution].
Quoix E, Mennecier B. Quoix E, et al. Among authors: mennecier b. Rev Pneumol Clin. 2003 Sep;59(4):187-95. Rev Pneumol Clin. 2003. PMID: 14699294 Review. French.
[Lung cancer in women].
Quoix E, Mennecier B. Quoix E, et al. Among authors: mennecier b. Rev Mal Respir. 2005 Dec;22(6 Pt 2):8S55-62. Rev Mal Respir. 2005. PMID: 16340837 Review. French.
[Hemolytic anemia under erlotinib treatment].
Sakhri L, Mennecier B, Quoix A. Sakhri L, et al. Among authors: mennecier b. Rev Pneumol Clin. 2013 Dec;69(6):345-50. doi: 10.1016/j.pneumo.2013.06.003. Epub 2013 Oct 31. Rev Pneumol Clin. 2013. PMID: 24183296 Review. French.
69 results